Trial site
Ponce Medical School Foundation Inc.
- 11running trials
- 7closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Obesity7 trials
- Type 2 diabetes5 trials
- Osteoarthritis3 trials
- Migraine2 trials
- Psoriasis2 trials
- Metastatic breast cancer1 trial
- Obstructive sleep apnoea1 trial
- Rheumatoid arthritis1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 314 trials
- Phase 22 trials
- Phase 41 trial
- Status
- Completed7 trials
- Active, not recruiting6 trials
- Recruiting5 trials
- Lead sponsor
- Eli Lilly and Company12 trials
- Alumis Inc2 trials
- Amgen2 trials
- Gilead Sciences1 trial
- Ponce Medical School Foundation, Inc.1 trial
Running trials
Recruiting
Recruiting
Recruiting
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
Recruiting
Active, not recruiting
Active, not recruiting
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
Active, not recruiting
A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
Active, not recruiting
Active, not recruiting
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine
Recruiting
Active, not recruiting
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity2 recruiting
- Osteoarthritis2 recruiting
Closed trials
Completed
Completed
Completed
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Completed
Completed
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
Completed
A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis
Site data: ClinicalTrials.govUpdated 15 Nov 2026